SAFE vs SRPT · P/E 11, rev $365.7M vs rev $1.90B
Safehold Inc (SAFE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Safehold Inc (SAFE) is a reit - diversified company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SAFE revenue for 2024-12-31 was $365.7M. Net income was $106.6M. Revenue was up 3.7% from 2023-12-31 to 2024-12-31. SAFE currently screens at market cap $1.10B and trailing P/E 10.5.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
SAFE currently screens at market cap $1.10B and trailing P/E 10.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the SAFE and SRPT stock pages for the full models.
Not investment advice.